A citation-based method for searching scientific literature

Ayanthi A Wijewardene, Marthe Chehade, Matti L Gild, Roderick J Clifton-Bligh, Martyn Bullock. Cancers (Basel) 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Multiple ETS Factors Participate in the Transcriptional Control of TERT Mutant Promoter in Thyroid Cancers.
Caitlin E M Thornton, Jingzhu Hao, Prasanna P Tamarapu, Iñigo Landa. Cancers (Basel) 2022
1
100

Genetic Profiles of Aggressive Variants of Papillary Thyroid Carcinomas.
Meihua Jin, Dong Eun Song, Jonghwa Ahn, Eyun Song, Yu-Mi Lee, Tae-Yon Sung, Tae Yong Kim, Won Bae Kim, Young Kee Shong, Min Ji Jeon,[...]. Cancers (Basel) 2021
6
50

RAC1 Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient.
Rozita Bagheri-Yarmand, Naifa L Busaidy, Elena McBeath, Brian P Danysh, Kurt W Evans, Tyler J Moss, Argun Akcakanat, Patrick K S Ng, Christina M Knippler, Jalyn A Golden,[...]. Cancers (Basel) 2021
3
50

Development of Novel Follicular Thyroid Cancer Models Which Progress to Poorly Differentiated and Anaplastic Thyroid Cancer.
Caitlin O Caperton, Lee Ann Jolly, Nicole Massoll, Andrew J Bauer, Aime T Franco. Cancers (Basel) 2021
2
50

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Rui Batista, Joana Peixoto, Catarina Tavares, Ricardo Celestino, Ana Almeida, Catarina Salgado, Catarina Eloy,[...]. J Clin Endocrinol Metab 2014
334
50

Gene Editing with CRISPR/Cas Methodology and Thyroid Cancer: Where Are We?
Cesar Seigi Fuziwara, Diego Claro de Mello, Edna Teruko Kimura. Cancers (Basel) 2022
1
100


Secreted Factors by Anaplastic Thyroid Cancer Cells Induce Tumor-Promoting M2-like Macrophage Polarization through a TIM3-Dependent Mechanism.
Cinthia Carolina Stempin, Romina Celeste Geysels, Sunmi Park, Luz Maria Palacios, Ximena Volpini, Claudia Cristina Motran, Eva Virginia Acosta Rodríguez, Juan Pablo Nicola, Sheue-Yann Cheng, Claudia Gabriela Pellizas,[...]. Cancers (Basel) 2021
5
50

APOBEC SBS13 Mutational Signature-A Novel Predictor of Radioactive Iodine Refractory Papillary Thyroid Carcinoma.
Sarah Siraj, Tariq Masoodi, Abdul K Siraj, Saud Azam, Zeeshan Qadri, Sandeep K Parvathareddy, Rong Bu, Khawar S Siddiqui, Saif S Al-Sobhi, Mohammed AlDawish,[...]. Cancers (Basel) 2022
2
50

MiRNA Deregulation Distinguishes Anaplastic Thyroid Carcinoma (ATC) and Supports Upregulation of Oncogene Expression.
Danny Misiak, Marcus Bauer, Jana Lange, Jacob Haase, Juliane Braun, Kerstin Lorenz, Claudia Wickenhauser, Stefan Hüttelmaier. Cancers (Basel) 2021
2
50



Differentiated Thyroid Cancer with Biochemical Incomplete Response: Clinico-Pathological Characteristics and Long Term Disease Outcomes.
Miriam Steinschneider, Jacob Pitaro, Shlomit Koren, Yuval Mizrakli, Carlos Benbassat, Limor Muallem Kalmovich. Cancers (Basel) 2021
4
50

Medullary Thyroid Carcinoma Mutational Spectrum Update and Signaling-Type Inference by Transcriptional Profiles: Literature Meta-Analysis and Study of Tumor Samples.
Emanuela Minna, Paola Romeo, Matteo Dugo, Loris De Cecco, Antonella Aiello, Federico Pistore, Andrea Carenzo, Angela Greco, Maria Grazia Borrello. Cancers (Basel) 2022
2
50

Biologic and Clinical Perspectives on Thyroid Cancer.
James A Fagin, Samuel A Wells. N Engl J Med 2016
421
50

Radio-Iodide Treatment: From Molecular Aspects to the Clinical View.
Antonio De la Vieja, Garcilaso Riesco-Eizaguirre. Cancers (Basel) 2021
11
50

Annual Hazard Rate of Recurrence in Middle Eastern Papillary Thyroid Cancer over a Long-Term Follow-Up.
Abdul K Siraj, Sandeep Kumar Parvathareddy, Zeeshan Qadri, Khawar Siddiqui, Saif S Al-Sobhi, Fouad Al-Dayel, Khawla S Al-Kuraya. Cancers (Basel) 2020
9
50

Evidence of Cooperation between Hippo Pathway and RAS Mutation in Thyroid Carcinomas.
Thaise Nayane Ribeiro Carneiro, Larissa Valdemarin Bim, Vanessa Candiotti Buzatto, Vanessa Galdeno, Paula Fontes Asprino, Eunjung Alice Lee, Pedro Alexandre Favoretto Galante, Janete Maria Cerutti. Cancers (Basel) 2021
2
50


Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A Knauf, Ronak H Shah, Snjezana Dogan, Julio C Ricarte-Filho, Gnana P Krishnamoorthy, Bin Xu,[...]. J Clin Invest 2016
560
50

Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma.
Antónia Afonso Póvoa, Elisabete Teixeira, Maria Rosa Bella-Cueto, Rui Batista, Ana Pestana, Miguel Melo, Thalita Alves, Mafalda Pinto, Manuel Sobrinho-Simões, Jorge Maciel,[...]. Cancers (Basel) 2021
4
50

Urine as a Source of Liquid Biopsy for Cancer.
Masanori Oshi, Vijayashree Murthy, Hideo Takahashi, Michelle Huyser, Maiko Okano, Yoshihisa Tokumaru, Omar M Rashid, Ryusei Matsuyama, Itaru Endo, Kazuaki Takabe. Cancers (Basel) 2021
14
50

Nipple Aspirate Fluid at a Glance.
Susana I S Patuleia, Karijn P M Suijkerbuijk, Elsken van der Wall, Paul J van Diest, Cathy B Moelans. Cancers (Basel) 2021
2
50

Single-molecule catalytic hairpin assembly for rapid and direct quantification of circulating miRNA biomarkers.
Xiuxue Hu, Jinbo Fan, Banyan Duan, Haiyan Zhang, Yuanyuan He, Peng Duan, Xiaoqiang Li. Anal Chim Acta 2018
18
50

Identification of Cell-Free Circulating MicroRNAs for the Detection of Early Breast Cancer and Molecular Subtyping.
Karen C B Souza, Adriane F Evangelista, Letícia F Leal, Cristiano P Souza, René A Vieira, Rhafaela L Causin, A C Neuber, Daniele P Pessoa, Geraldo A S Passos, Rui M V Reis,[...]. J Oncol 2019
19
50

Circulating Biomarkers in Breast Cancer.
Katelyn N Seale, Katherine H R Tkaczuk. Clin Breast Cancer 2022
9
50

Multi-miRNA panel of tumor-derived extracellular vesicles as promising diagnostic biomarkers of early-stage breast cancer.
Min Woo Kim, Sunyoung Park, Hyojung Lee, Hogyeong Gwak, Kyung-A Hyun, Jee Ye Kim, Hyo-Il Jung, Seung Il Kim. Cancer Sci 2021
9
50

Human salivary microRNAs in Cancer.
Óscar Rapado-González, Blanca Majem, Laura Muinelo-Romay, Ana Álvarez-Castro, Anna Santamaría, Antonio Gil-Moreno, Rafael López-López, María Mercedes Suárez-Cunqueiro. J Cancer 2018
37
50

Circulating miR-532-502 cluster derived from chromosome X as biomarkers for diagnosis of breast cancer.
Xuan Zou, Minghui Li, Zebo Huang, Xin Zhou, Qingxie Liu, Tiansong Xia, Wei Zhu. Gene 2020
12
50

Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
Amal Qattan, Haya Intabli, Wafa Alkhayal, Chafica Eltabache, Taher Tweigieri, Suad Bin Amer. BMC Cancer 2017
43
50

Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
Eman A Elghoroury, Hesham G ElDine, Solaf A Kamel, Amany H Abdelrahman, Asmaa Mohammed, Mahmoud M Kamel, Mona H Ibrahim. Clin Breast Cancer 2018
38
50

First microRNA mimic enters clinic.
Aaron Bouchie. Nat Biotechnol 2013
329
50

Clinical Utility of Liquid Biopsy-Based Actionable Mutations Detected via ddPCR.
Irina Palacín-Aliana, Noemí García-Romero, Adrià Asensi-Puig, Josefa Carrión-Navarro, Víctor González-Rumayor, Ángel Ayuso-Sacido. Biomedicines 2021
3
50

Advantages and Disadvantages of Mammography Screening.
Sylvia H Heywang-Köbrunner, Astrid Hacker, Stefan Sedlacek. Breast Care (Basel) 2011
42
50

Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation.
Jacob O'Brien, Heyam Hayder, Yara Zayed, Chun Peng. Front Endocrinol (Lausanne) 2018
50

Fecal MicroRNAs as Potential Biomarkers for Screening and Diagnosis of Intestinal Diseases.
Humaira Rashid, Biplob Hossain, Towfida Siddiqua, Mamun Kabir, Zannatun Noor, Mamun Ahmed, Rashidul Haque. Front Mol Biosci 2020
11
50

Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
Takaaki Masuda, Yoshiaki Shinden, Miwa Noda, Hiroki Ueo, Qingjiang Hu, Yukihiro Yoshikawa, Yusuke Tsuruda, Yosuke Kuroda, Shuhei Ito, Hidetoshi Eguchi,[...]. Anticancer Res 2018
19
50

Pathway Analysis of Selected Circulating miRNAs in Plasma of Breast Cancer Patients: A Preliminary Study.
Veronika Holubekova, Zuzana Kolkova, Marian Grendar, Dusan Brany, Dana Dvorska, Igor Stastny, Marianna Jagelkova, Katarina Zelinova, Marek Samec, Alena Liskova,[...]. Int J Mol Sci 2020
9
50

Plasma exosome microRNAs are indicative of breast cancer.
Bethany N Hannafon, Yvonne D Trigoso, Cameron L Calloway, Y Daniel Zhao, David H Lum, Alana L Welm, Zhizhuang J Zhao, Kenneth E Blick, William C Dooley, W Q Ding. Breast Cancer Res 2016
300
50

Circulating miRNAs with prognostic value in metastatic breast cancer and for early detection of metastasis.
Dharanija Madhavan, Cike Peng, Markus Wallwiener, Manuela Zucknick, Juliane Nees, Sarah Schott, Anja Rudolph, Sabine Riethdorf, Andreas Trumpp, Klaus Pantel,[...]. Carcinogenesis 2016
96
50

Potential value of circulatory microRNA10b gene expression and its target E-cadherin as a prognostic and metastatic prediction marker for breast cancer.
Fatma Ibrahim Dwedar, Reham Said Shams-Eldin, Salwa Nayer Mohamed, Ayman Farouk Mohammed, Salwa Hamdi Gomaa. J Clin Lab Anal 2021
4
50

Exosomes in Cancer Liquid Biopsy: A Focus on Breast Cancer.
Sina Halvaei, Shiva Daryani, Zahra Eslami-S, Tannaz Samadi, Narges Jafarbeik-Iravani, Tayebeh Oghabi Bakhshayesh, Keivan Majidzadeh-A, Rezvan Esmaeili. Mol Ther Nucleic Acids 2018
99
50

High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
Biyun Qian, Dionyssios Katsaros, Lingeng Lu, Mario Preti, Antonio Durando, Riccardo Arisio, Lina Mu, Herbert Yu. Breast Cancer Res Treat 2009
203
50

A Pilot Study on MicroRNA Profile in Tear Fluid to Predict Response to Anti-VEGF Treatments for Diabetic Macular Edema.
Hwei Wuen Chan, Binxia Yang, Wendy Wong, Paul Blakeley, Ivan Seah, Queenie Shu Woon Tan, Haofei Wang, Mayuri Bhargava, Hazel Anne Lin, Charmaine Hc Chai,[...]. J Clin Med 2020
6
50


Exosomal miR-1910-3p promotes proliferation, metastasis, and autophagy of breast cancer cells by targeting MTMR3 and activating the NF-κB signaling pathway.
Bo Wang, Jia-Hui Mao, Bing-Ying Wang, Ling-Xia Wang, Hui-Yan Wen, Long-Jiang Xu, Jin-Xiang Fu, Huan Yang. Cancer Lett 2020
56
50

MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers.
Benjamin L Jackson, Anna Grabowska, Hari L Ratan. BMC Cancer 2014
61
50


Genomic instability-derived plasma extracellular vesicle-microRNA signature as a minimally invasive predictor of risk and unfavorable prognosis in breast cancer.
Siqi Bao, Ting Hu, Jiaqi Liu, Jianzhong Su, Jie Sun, Yue Ming, Jiaxin Li, Nan Wu, Hongyan Chen, Meng Zhou. J Nanobiotechnology 2021
29
50

Emergence of Circulating MicroRNAs in Breast Cancer as Diagnostic and Therapeutic Efficacy Biomarkers.
Vaishali Aggarwal, Kumari Priyanka, Hardeep Singh Tuli. Mol Diagn Ther 2020
30
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.